+++
# Selected Publications widget.
# Note: this widget will only display if `content/publication/` contains publications
# with `selected = true` in their `+++` preamble.

date = "2019-01-20T00:00:00"
draft = false

title = "Selected Publications"
subtitle = ""
widget = "publications_selected"

# Order that this section will appear in.
weight = 10

# Show publication details (such as abstract)? (true/false)
detailed_list = true

+++

### [H-index=22, i10-index=39, citations=1137] (https://scholar.google.co.uk/citations?user=-eYVFlgAAAAJ&hl=en)
1. H. Kentala, A. Koponen, A.M. Kivela, R. Andrews, C. Li, `Y. Zhou`, V.M. Olkkonen, Analysis of ORP2 knockout hepatocytes uncovers a novel function in actin cytoskeletal regulation, FASEB J. (2018) fj201700604R. (IF= 5.498)
2. S.Y. Qin, D.H. Lu, X.Y. Guo, W. Luo, B.L. Hu, X.L. Huang, M. Chen, J.X. Wang, S.J. Ma, X.W. Yang, H.X. Jiang#, `Y. Zhou#`, A deleterious role for Th9/IL-9 in hepatic fibrogenesis, Sci. Rep. 6 (2016) 18694. (IF=4.259). 
**Recommended by [*Faculty of 1000*] (http://f1000.com/prime/726054174): ★★ "New Finding", "Novel Drug Target" and "Elegant study".**
3.	`Y. Zhou#`, G. Llaurado#, M. Oresic, T. Hyotylainen, M. Orho-Melander, H. Yki-Jarvinen, Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2, J. Hepatol. 62 (2015) 657-663.
(IF= 14.911)
4.	`Y. Zhou`, M. Oresic, M. Leivonen, P. Gopalacharyulu, J. Hyysalo, J. Arola, A. Verrijken, S. Francque, L. Van Gaal, T. Hyotylainen, H. Yki-Jarvinen, Noninvasive detection of nonalcoholic steatohepatitis using clinical markers and circulating levels of lipids and metabolites, Clin. Gastroenterol. Hepatol. 14 (2016) 1463-1472.e6 (IF=7.683).  
**Featured in [*Daily Express*] (t.co/pGkZEdL7uA), [*Cardiff Star*] (http://www.cardiffstar.com/news/248327275/simple-blood-test-may-enhance-diagnosis-rate-of-severe-liver-disease), [*New Atlas*] (http://newatlas.com/nash-liver-disease-blood-test/45819/), [*Bioanalysis-zone*] (https://www.bioanalysis-zone.com/2016/10/24/simple-blood-test-improve-detection-rates-severe-liver-disease/), [*Associació Catalana de Malalts d'Hepatitis*] (http://asscat-hepatitis.org/blog/hacia-diagnostico-no-invasivo-la-forma-mas-grave-higado-graso/), [*Cardiff University News*] (https://www.cardiff.ac.uk/news/view/482735-non-invasive-diagnosis) etc.**
5.	P.K. Luukkonen#, `Y. Zhou#`, S S. Sadevirta, M. Leivonen, J. Arola, M. Oresic, T. Hyotylainen, H. Yki-Jarvinen, Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease, J. Hepatol. 64 (2016) 1167-1175.  (`IF= 14.911`). Recommended by Faculty of 1000: https://f1000.com/prime/726082214
**Highly cited paper awarded by the Essential Science IndicatorsTM (ESI): citations ranked top 1% of the academic field of Clinical Medicine.**
6. P.K. Luukkonen, S. Sadevirta, `Y. Zhou`, B. Kayser, A. Ali, L. Ahonen, S. Lallukka, V. Pelloux, M. Gaggini, C. Jian, A. Hakkarainen, N. Lundbom, H. Gylling, A. Salonen, M. Oresic, T. Hyotylainen, M. Orho-Melander, A. Rissanen, A. Gastaldelli, K. Clement, L. Hodson, H. Yki-Jarvinen, Saturated fat is more metabolically harmful for the human liver than unsaturated fat or simple sugars, Diabetes Care. 41 (2018) 1732-1739 (IF = 13.397).                           
**Commented in [*New York Times*] (https://www.nytimes.com/2018/10/29/well/live/confused-by-nutrition-research-sloppy-science-may-be-to-blame.html)**
7. Z. Liu#, `Y. Zhou#`, G. Liang, Y. Ling, W. Tan, L. Tan, R. Andrews, W. Zhong, X. Zhang, E. Song, C. Gong, Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p, Cell. Death Dis. 10 (2019) 55-018-1287-1. (*:co-first author, IF= 5.638)
7. P.K. Luukkonen, `Y. Zhou`, P.A. Nidhina Haridas, O.P. Dwivedi, T. Hyotylainen, A. Ali, A. Juuti, M. Leivonen, T. Tukiainen, L. Ahonen, E. Scott, J.M. Palmer, J. Arola, M. Orho-Melander, P. Vikman, Q.M. Anstee, V.M. Olkkonen, M. Oresic, L. Groop, H. Yki-Jarvinen, Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD, J. Hepatol. 67 (2017) 128-136.  (IF=14.911)
9.	P.K. Luukkonen, `Y. Zhou`, T. Hyotylainen, M. Leivonen, J. Arola, M. Orho-Melander, M. Oresic, H. Yki-Jarvinen, The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans, J. Hepatol. 65 (2016) 1263-1265.  (IF= 14.911)
10.	S.Y. Qin, J. Liu, H.X. Jiang, B.L. Hu, `Y. Zhou#`, V.M. Olkkonen#. Association between baseline Lipoprotein (a) levels and restenosis after coronary stenting: Meta-analysis of 9 cohort studies, Atherosclerosis. 227 (2013) 360-366.
11. J. Hyysalo#, V.T. Mannisto#, `Y. Zhou`, J. Arola, V. Karja, M. Leivonen, A. Juuti, N. Jaser, S. Lallukka, P. Kakela, S. Venesmaa, M. Simonen, J. Saltevo, L. Moilanen, E. Korpi-Hyovalti, S. Keinanen-Kiukaanniemi, H. Oksa, M. Orho-Melander, L. Valenti, S. Fargion, J. Pihlajamaki, M. Peltonen, H. Yki-Jarvinen, A population-based study on the prevalence of NASH using scores validated against liver histology. J. Hepatol. 60 (2014) 839-846. (IF=14.911)